Explore more about: Point of Care Technologies - Diagnostics

To date, nine medical device developers participating in the RADx® Tech Independent Test Assessment Program have received emergency use authorization for at-home and point-of care test products that simultaneously detect COVID-19 and flu A/B.

NIH announced finalists in its competition to accelerate development of diagnostic and monitoring technologies to improve fetal health outcomes in low-resource settings.

The federal government has expanded the Home Test to Treat program, an entirely virtual community health program that offers free COVID-19 health services.

NIH will advance the development of home-based and point-of-care health technologies with awards to six technology research and development centers around the country. The centers comprise the Point of Care Technology Research Network (POCTRN) and will parlay the momentum of the original network established in 2007 by the NIBIB.

The Rapid Acceleration of Diagnostics Technology (RADx® Tech) Fetal Monitoring Challenge calls on scientists, engineers, and clinicians around the country to submit their innovative approaches and compete for prizes and additional resources to support technology development and clinical impact.

Some people using antigen tests have experienced a negative test result only to find out that they have the virus. New research shows that repeat testing every other day increases the detection of the SARS-CoV-2 virus.

New recommendations from the NIH Rapid Acceleration of Diagnostics (RADx®) Tech Program provide a blueprint for the design and manufacture of more accessible diagnostic tests.

NIH has launched the Home Test to Treat program, an entirely virtual community health intervention that will provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities.

A research team funded by the National Institutes of Health has shown that commercially available rapid antigen tests can detect past and present variants of concern and has identified potential mutations that may impact test performance in the future.

A new study that could have immediate implications for COVID-19 testing in schools found that with age-appropriate instructions, school-aged children can successfully use a nasal swab to obtain their own COVID-19 test specimen.